- You can view the full Express Scripts Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Chuck Grassley is hammering the privately held drug company on its $4,500 EpiPen competitor.
I believe this president goes full Trumpian tonight, in a style that he has made all his own.